Indication · ntm-pd not meeting its primary endpoint

ntm-pd not meeting its primary endpoint FDA approvals, PDUFA dates and pipeline.

Updated Snapshot 20261116T222116ZBuilt

We track 1 ntm-pd not meeting its primary endpoint drug. No FDA approvals recorded yet.

Drugs

DrugSponsorModalityDesignations
SPR720SPRO—Fast Track, Orphan Drug

Upcoming catalysts

No events in this view.

Past catalysts and decisions

DateDrugCompanyEventIndicationStatusSource
October 29, 2024SPR720SPROInterim readoutNTM-PD not meeting its primary endpointMet primary endpointSEC Form 10-Q

All indications · Approval rates by indication

Not submitted to search engines: Needs 2 drugs and 3 sourced events; has 1 and 1.

Questions

What ntm-pd not meeting its primary endpoint drugs have upcoming PDUFA dates?

None disclosed.

Built from primary public sources only: sponsor SEC filings (8-K, EX-99.1, 10-Q, 10-K), the FDA advisory committee calendar, FDA Novel Drug Approvals and Complete Response Letter records, openFDA, and ClinicalTrials.gov (U.S. National Library of Medicine). Every row links the sentence it came from. Dates move; the linked source is authoritative. Not investment or medical advice.

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.